Medical Innovation Exchange

AbbVie stops second CD47 study early, dropping out of AML race it joined in $2B biobuck deal

https://www.fiercebiotech.com/biotech/abbvie-stops-second-cd47-study-early-dropping-out-aml-race-it-joined-2b-biobuck-deal

Leave a Comment

Your email address will not be published.

Leave the field below empty!